<DOC>
	<DOCNO>NCT00810758</DOCNO>
	<brief_summary>To assess safety , tolerability , pharmacokinetics pharmacodynamics multiple oral dos PF-04878691 .</brief_summary>
	<brief_title>Multiple Oral Dose Study Evaluate Safety , Tolerability , Pharmacokinetics Pharmacodynamics PF-04878691</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Healthy male and/or female subject age 1855 , inclusive . Body Mass Index ( BMI ) 1830 kg/m2 ; total body weight &gt; 50kg ( 110lbs ) . Pregnant nursing female . Females childbearing potential . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic autoimmune disease clinical finding screen . Smoking within previous 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>HCV</keyword>
	<keyword>Toll-like receptor 7</keyword>
	<keyword>Multiple oral dose escalation study PF-04878691</keyword>
</DOC>